您的位置: 首页 > 农业专利 > 详情页

tumor-associated epitope that stimulates an immune reaction against the tumor for use in medicine; tumor-associated epitope that stimulates an immune reaction against the tumor, and / or a nucleic acid; epitope for use; epitope and / or nucleic acid for use; epitope; peptide; modified epitope that stimulates an immune reaction of il-10 against autoantigens for use in medicine; method for predicting survival in colorectal cancer; and method for predicting survival in ovarian cancer.
专利权人:
SCANCELL LIMITED
发明人:
LINDA GILLIAN DURRANT,RACHEL LOUISE METHERINGHAM,VICTORIA ANNE BRENTVILLE
申请号:
BR112015002574
公开号:
BR112015002574A8
申请日:
2013.08.07
申请国别(地区):
BR
年份:
2018
代理人:
摘要:
The present invention relates to the use of nucleic acids comprising sequences that encode tumour-associated epitopes in medicine and in particular in the treatment of cancer. The epitopes stimulate an immune reaction against the tumour and have a modification of deimination of arginine to citrulline.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充